Patient Trajectories for Older Adults Admitted to Hospital for Alcohol-related Problems
Launched by HELSE STAVANGER HF · Nov 14, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how older adults who are admitted to the hospital for problems related to alcohol use are affected by brief interventions aimed at reducing their alcohol consumption. The researchers want to understand the journey of these patients by looking at their health and behavior three years before and after their hospital stay. This is important because alcohol-related issues are becoming more common among older adults, and the goal is to find out how effective hospital screenings and brief counseling can be in helping them make healthier choices.
To participate in the study, individuals must be at least 21 years old, have been admitted to a hospital that is using these screening strategies, and give their written consent to join. They should not have a history of alcohol or drug use disorders before the study. Participants can expect to have their health data monitored over a six-year period, which will provide valuable insights into how these brief interventions impact their alcohol use and overall health. This study aims to improve support and treatment for older adults facing alcohol-related challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 21 or older, no previous alcohol use disorder or substance use disorder, admitted to hospital which has implemented screening and brief alcohol intervention strategies, written consent to participate
- Exclusion Criteria:
- • specialized treatment for alcohol use disorder og drug use disorder during the three years prior to recruitment
About Helse Stavanger Hf
Helse Stavanger HF is a leading healthcare organization based in Norway, dedicated to providing high-quality medical services and advancing clinical research. As a prominent sponsor of clinical trials, Helse Stavanger HF focuses on innovative therapeutic interventions across various medical fields, aiming to enhance patient care and outcomes. With a commitment to ethical research practices and collaboration with academic institutions, the organization plays a vital role in the development of new treatments and the improvement of healthcare standards in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stavanger, , Norway
Patients applied
Trial Officials
Torgeir G Lid, MD PhD
Principal Investigator
Helse Stavanger HF
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials